P/E ratio for Avinger (AVGR)
P/E ratio as of May 2024 (TTM): -0.1185
According to Avinger's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.118469. At the end of 2022 the company had a P/E ratio of -0.0153.
P/E ratio history for Avinger from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0153 | -88.37% |
| 2021 | -0.1313 | 258.07% |
| 2020 | -0.0367 | 71.27% |
| 2019 | -0.0214 | 359.02% |
| 2018 | -0.0047 | -50.7% |
| 2017 | -0.0095 | -86.65% |
| 2016 | -0.0709 | -81.28% |
| 2015 | -0.3785 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Utah Medical Products UTMD | 14.6 | -12,421.79% | 🇺🇸 USA |
 SurModics SRDX | -19.7 | 16,521.14% | 🇺🇸 USA |
 ICU Medical
ICUI | -49.5 | 41,683.08% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.